Company’s underperformance linked to restrictions on investing in vaccine stocks
Thursday 22 Jul 2021 Author: Martin Gamble
When Kate Bingham, managing partner of SV Health Managers LLP was appointed chair of the UK Vaccine Task Force by the Government, it made life awkward for the team managing the International Biotechnology Trust ( IBT ) . That’s because Bingham oversees the unquoted part of the portfolio, representing around 11.2% of the trust’s assets and to ensure there were no conflicts of interest, the managers precluded themselves from...